Cradle Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-06-2024
- Paid Up Capital ₹ 1.91 M
as on 17-06-2024
- Company Age 16 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.33 Cr
as on 17-06-2024
- Revenue 48.10%
(FY 2023)
- Profit 58.11%
(FY 2023)
- Ebitda 10.83%
(FY 2023)
- Net Worth 16.40%
(FY 2023)
- Total Assets 8.14%
(FY 2023)
About Cradle Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.91 M.
The company currently has active open charges totaling ₹7.33 Cr.
Sanjiv Sinha, Rajnish Pandey, Satish Pandey, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24232BR2008PTC014097
- Company No.
014097
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cradle Life Sciences Private Limited offer?
Cradle Life Sciences Private Limited offers a wide range of products and services, including Herbal Sexual Health Supplement, Ayurvedic Erectile Dysfunction Capsules and Tablets, Anti Inflammatory Drugs, Deflazacort.
Who are the key members and board of directors at Cradle Life Sciences?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiv Sinha  | Director | 08-Dec-2008 | Current |
| Rajnish Pandey | Director | 08-Dec-2008 | Current |
| Satish Pandey | Director | 08-Dec-2008 | Current |
| Prashant Dubey | Director | 08-Dec-2008 | Current |
| Rolly Kumari | Director | 11-Mar-2021 | Current |
| Mani Pandey | Director | 10-Nov-2011 | Current |
Financial Performance of Cradle Life Sciences.
Cradle Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.1% increase. The company also saw a substantial improvement in profitability, with a 58.11% increase in profit. The company's net worth Soared by an impressive increase of 16.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cradle Life Sciences?
In 2022, Cradle Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Cradle Life Sciences (Pharma) Private LimitedActive 4 years 10 monthsSanjiv Sinha, Rajnish Pandey and 5 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Oct 2022 | ₹1.11 M | Open |
Hdfc Bank Limited Creation Date: 11 Jun 2021 | ₹0.81 M | Open |
Hdfc Bank Limited Creation Date: 05 May 2021 | ₹1.66 Cr | Open |
How Many Employees Work at Cradle Life Sciences?
Cradle Life Sciences has a workforce of 94 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cradle Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cradle Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
